Chinese english Germany Japanese Korea

1-Methyl-2-piperazin-1-yl-1H-benzoiMidazole hydrochloride, 98+% C12H17ClN4, MW: 252.75

1-Methyl-2-piperazin-1-yl-1H-benzoiMidazole hydrochloride, 98+% C12H17ClN4, MW: 252.75 Struktur
1185319-78-1
CAS-Nr.
1185319-78-1
Englisch Name:
1-Methyl-2-piperazin-1-yl-1H-benzoiMidazole hydrochloride, 98+% C12H17ClN4, MW: 252.75
Synonyma:
1-Methyl-2-(1-piperazinyl)-1H-benzimidazole hydrochloride;1-Methyl-2-(piperazin-1-yl)-1H-benzo[d]iMidazole hydrochloride;1-Methyl-2-piperazin-1-yl-1H-benzoiMidazole hydrochloride, 98+% C12H17ClN4, MW: 252.75
CBNumber:
CB22593229
Summenformel:
C12H17ClN4
Molgewicht:
252.74318
MOL-Datei:
1185319-78-1.mol
Request For Quotation

1-Methyl-2-piperazin-1-yl-1H-benzoiMidazole hydrochloride, 98+% C12H17ClN4, MW: 252.75 Eigenschaften

storage temp. 
Sealed in dry,Room Temperature

Sicherheit

1-Methyl-2-piperazin-1-yl-1H-benzoiMidazole hydrochloride, 98+% C12H17ClN4, MW: 252.75 Chemische Eigenschaften,Einsatz,Produktion Methoden

1-Methyl-2-piperazin-1-yl-1H-benzoiMidazole hydrochloride, 98+% C12H17ClN4, MW: 252.75 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

1-Methyl-2-piperazin-1-yl-1H-benzoiMidazole hydrochloride, 98+% C12H17ClN4, MW: 252.75 Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 5)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Alchem Pharmtech,Inc. 		8485655694
sales@alchempharmtech.com United States 63711 58
Meryer (Shanghai) Chemical Technology Co., Ltd. 021-61259108 18621169109
 market03@meryer.com China 40240 62
Amber MolTech LLC 086-010-62176588
amber@jyamber.com China 10152 56
Shanghai Sunway Pharmaceutical Technology Co.,Ltd. 021-51816796-820 13611835272
 sales2@sunwaypharm.com China 44482 58
  • 1-Methyl-2-piperazin-1-yl-1H-benzoiMidazole hydrochloride, 98+% C12H17ClN4, MW: 252.75
  • 1-Methyl-2-(1-piperazinyl)-1H-benzimidazole hydrochloride
  • 1-Methyl-2-(piperazin-1-yl)-1H-benzo[d]iMidazole hydrochloride
  • 1185319-78-1
Copyright 2019 © ChemicalBook. All rights reserved